78/100B107.460
USD
1.63
(1.54%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Edwards Lifesciences's current ratio is 4.60: current assets of 7.25B USD against current liabilities of 1.58B USD due within a year.
- Today
- 4.60
- Average, 5 years
- 3.75
- Low, 5 years
- 3.01
- High, 5 years
- 4.68
Current ratio = current assets ÷ current liabilities = 7.25B ÷ 1.58B = 4.60
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 4.60 | 7.25B | 1.58B | |
| FY2025 | 31 Dec 2025 | 3.72 | 6.74B | 1.81B |
| FY2024 | 31 Dec 2024 | 4.18 | 6.29B | 1.51B |
| FY2023 | 31 Dec 2023 | 3.38 | 4.04B | 1.20B |
| FY2022 | 31 Dec 2022 | 3.03 | 3.10B | 1.02B |
| FY2021 | 31 Dec 2021 | 3.08 | 3.18B | 1.03B |
| FY2020 | 31 Dec 2020 | 3.46 | 3.09B | 893.90M |
| FY2019 | 31 Dec 2019 | 3.31 | 2.98B | 902.40M |
| FY2018 | 31 Dec 2018 | 2.61 | 2.29B | 876.60M |
| FY2017 | 31 Dec 2017 | 1.81 | 2.53B | 1.40B |
| FY2016 | 31 Dec 2016 | 4.21 | 2.24B | 532.50M |
| FY2015 | 31 Dec 2015 | 4.30 | 2.05B | 476.20M |
| FY2014 | 31 Dec 2014 | 5.28 | 2.29B | 434.40M |
| FY2013 | 31 Dec 2013 | 4.99 | 1.73B | 345.60M |
| FY2012 | 31 Dec 2012 | 3.72 | 1.29B | 347.40M |
| FY2011 | 31 Dec 2011 | 3.49 | 1.17B | 335.20M |
| FY2010 | 31 Dec 2010 | 3.06 | 1.03B | 337.80M |
| FY2009 | 31 Dec 2009 | 3.06 | 889.20M | 290.50M |
| FY2008 | 31 Dec 2008 | 2.68 | 691.90M | 258.50M |
| FY2007 | 31 Dec 2007 | 1.55 | 581.70M | 375.40M |
| FY2006 | 31 Dec 2006 | 2.35 | 531.60M | 226.20M |
| FY2005 | 31 Dec 2005 | 2.65 | 514.20M | 194.20M |
| FY2004 | 31 Dec 2004 | 1.88 | 367.50M | 195.40M |
| FY2003 | 31 Dec 2003 | 2.15 | 360.20M | 167.20M |
| FY2002 | 31 Dec 2002 | 1.65 | 326.40M | 197.90M |
| FY2001 | 31 Dec 2001 | 1.59 | 293.00M | 184.00M |
| FY2000 | 31 Dec 2000 | 1.29 | 282.00M | 219.00M |
| FY1999 | 31 Dec 1999 | 2.28 | 356.00M | 156.00M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 4.60 | 7.25B | 1.58B |
| Q2 FY2026 | 30 Jun 2026 | 4.52 | 6.82B | 1.51B |
| Q1 FY2026 | 31 Mar 2026 | 4.42 | 6.23B | 1.41B |
| Q4 FY2025 | 31 Dec 2025 | 3.72 | 6.74B | 1.81B |
| Q3 FY2025 | 30 Sept 2025 | 4.00 | 6.36B | 1.59B |
| Q2 FY2025 | 30 Jun 2025 | 4.68 | 6.58B | 1.40B |
| Q1 FY2025 | 31 Mar 2025 | 4.45 | 6.21B | 1.39B |
| Q4 FY2024 | 31 Dec 2024 | 4.18 | 6.29B | 1.51B |
| Q3 FY2024 | 30 Sept 2024 | 3.46 | 6.73B | 1.94B |
| Q2 FY2024 | 30 Jun 2024 | 3.71 | 4.52B | 1.22B |
| Q1 FY2024 | 31 Mar 2024 | 3.75 | 4.17B | 1.11B |
| Q4 FY2023 | 31 Dec 2023 | 3.38 | 4.04B | 1.20B |
| Q3 FY2023 | 30 Sept 2023 | 3.28 | 4.07B | 1.24B |
| Q2 FY2023 | 30 Jun 2023 | 3.15 | 3.65B | 1.16B |
| Q1 FY2023 | 31 Mar 2023 | 3.01 | 3.26B | 1.08B |
| Q4 FY2022 | 31 Dec 2022 | 3.03 | 3.10B | 1.02B |
| Q3 FY2022 | 30 Sept 2022 | 3.83 | 3.51B | 917.90M |
| Q2 FY2022 | 30 Jun 2022 | 3.37 | 3.26B | 969.10M |
| Q1 FY2022 | 31 Mar 2022 | 3.41 | 3.24B | 949.90M |
| Q4 FY2021 | 31 Dec 2021 | 3.08 | 3.18B | 1.03B |
| Q3 FY2021 | 30 Sept 2021 | 3.64 | 3.52B | 966.50M |
| Q2 FY2021 | 30 Jun 2021 | 3.75 | 3.32B | 886.20M |
| Q1 FY2021 | 31 Mar 2021 | 3.84 | 3.07B | 799.00M |
| Q4 FY2020 | 31 Dec 2020 | 3.46 | 3.09B | 893.90M |
| Q3 FY2020 | 30 Sept 2020 | 3.52 | 2.98B | 846.30M |
| Q2 FY2020 | 30 Jun 2020 | 3.08 | 2.69B | 873.20M |
| Q1 FY2020 | 31 Mar 2020 | 3.36 | 2.51B | 746.90M |
| Q4 FY2019 | 31 Dec 2019 | 3.31 | 2.98B | 902.40M |
| Q3 FY2019 | 30 Sept 2019 | 3.53 | 2.74B | 775.80M |
| Q2 FY2019 | 30 Jun 2019 | 3.38 | 2.35B | 697.00M |
| Q1 FY2019 | 31 Mar 2019 | 3.66 | 2.37B | 646.50M |
| Q4 FY2018 | 31 Dec 2018 | 2.61 | 2.29B | 876.60M |
| Q3 FY2018 | 30 Sept 2018 | 2.31 | 2.91B | 1.26B |
| Q2 FY2018 | 30 Jun 2018 | 2.28 | 2.70B | 1.18B |
| Q1 FY2018 | 31 Mar 2018 | 2.07 | 2.72B | 1.31B |
| Q4 FY2017 | 31 Dec 2017 | 1.81 | 2.53B | 1.40B |
| Q3 FY2017 | 30 Sept 2017 | 3.49 | 2.57B | 735.20M |
| Q2 FY2017 | 30 Jun 2017 | 4.06 | 2.28B | 562.50M |
| Q1 FY2017 | 31 Mar 2017 | 3.45 | 2.02B | 584.80M |
| Q4 FY2016 | 31 Dec 2016 | 4.21 | 2.24B | 532.50M |
| Q3 FY2016 | 30 Sept 2016 | 4.08 | 2.17B | 532.80M |
| Q2 FY2016 | 30 Jun 2016 | 4.15 | 1.99B | 478.20M |
| Q1 FY2016 | 31 Mar 2016 | 3.97 | 1.82B | 458.30M |
| Q4 FY2015 | 31 Dec 2015 | 4.30 | 2.05B | 476.20M |
| Q3 FY2015 | 30 Sept 2015 | 4.03 | 2.15B | 532.50M |
| Q2 FY2015 | 30 Jun 2015 | 5.16 | 2.30B | 445.20M |
| Q1 FY2015 | 31 Mar 2015 | 5.56 | 2.25B | 405.30M |
| Q4 FY2014 | 31 Dec 2014 | 5.28 | 2.29B | 434.40M |
| Q3 FY2014 | 30 Sept 2014 | 5.40 | 2.31B | 427.80M |
| Q2 FY2014 | 30 Jun 2014 | 4.21 | 2.28B | 540.50M |
| Q1 FY2014 | 31 Mar 2014 | 4.50 | 1.60B | 356.20M |
| Q4 FY2013 | 31 Dec 2013 | 4.99 | 1.73B | 345.60M |
| Q3 FY2013 | 30 Sept 2013 | 4.69 | 1.57B | 335.10M |
| Q2 FY2013 | 30 Jun 2013 | 4.43 | 1.39B | 314.20M |
| Q1 FY2013 | 31 Mar 2013 | 4.53 | 1.36B | 300.40M |
| Q4 FY2012 | 31 Dec 2012 | 3.72 | 1.29B | 347.40M |
| Q3 FY2012 | 30 Sept 2012 | 4.65 | 1.39B | 298.60M |
| Q2 FY2012 | 30 Jun 2012 | 4.50 | 1.28B | 284.30M |
| Q1 FY2012 | 31 Mar 2012 | 4.48 | 1.19B | 265.20M |
| Q4 FY2011 | 31 Dec 2011 | 3.49 | 1.17B | 335.20M |
| Q3 FY2011 | 30 Sept 2011 | 3.91 | 1.18B | 302.00M |
| Q2 FY2011 | 30 Jun 2011 | 3.88 | 1.22B | 313.30M |
| Q1 FY2011 | 31 Mar 2011 | 2.58 | 1.15B | 445.20M |
| Q4 FY2010 | 31 Dec 2010 | 3.06 | 1.03B | 337.80M |
| Q3 FY2010 | 30 Sept 2010 | 3.52 | 992.40M | 281.60M |
| Q2 FY2010 | 30 Jun 2010 | 3.71 | 918.90M | 247.70M |
| Q1 FY2010 | 31 Mar 2010 | 3.60 | 872.70M | 242.20M |
| Q4 FY2009 | 31 Dec 2009 | 3.06 | 889.20M | 290.50M |
| Q3 FY2009 | 30 Sept 2009 | 3.06 | 863.00M | 282.10M |
| Q2 FY2009 | 30 Jun 2009 | 3.04 | 745.60M | 245.10M |
| Q1 FY2009 | 31 Mar 2009 | 3.24 | 649.00M | 200.20M |
| Q4 FY2008 | 31 Dec 2008 | 2.68 | 691.90M | 258.50M |
| Q3 FY2008 | 30 Sept 2008 | 2.94 | 676.30M | 229.90M |
| Q2 FY2008 | 30 Jun 2008 | 2.80 | 635.10M | 226.60M |
| Q1 FY2008 | 31 Mar 2008 | 1.51 | 591.60M | 391.60M |
| Q4 FY2007 | 31 Dec 2007 | 1.55 | 581.70M | 375.40M |
| Q3 FY2007 | 30 Sept 2007 | 1.62 | 564.80M | 348.80M |
| Q2 FY2007 | 30 Jun 2007 | 1.67 | 541.20M | 323.60M |
| Q1 FY2007 | 31 Mar 2007 | 3.02 | 542.10M | 179.40M |
| Q4 FY2006 | 31 Dec 2006 | 2.35 | 531.60M | 226.20M |
| Q3 FY2006 | 30 Sept 2006 | 2.31 | 524.90M | 227.50M |
| Q2 FY2006 | 30 Jun 2006 | 2.39 | 542.30M | 226.50M |
| Q1 FY2006 | 31 Mar 2006 | 2.67 | 526.00M | 197.00M |
| Q4 FY2005 | 31 Dec 2005 | 2.65 | 514.20M | 194.20M |
| Q3 FY2005 | 30 Sept 2005 | 2.10 | 430.40M | 204.60M |
| Q2 FY2005 | 30 Jun 2005 | 2.30 | 437.10M | 190.40M |
| Q1 FY2005 | 31 Mar 2005 | 2.27 | 400.60M | 176.40M |
| Q4 FY2004 | 31 Dec 2004 | 1.88 | 367.50M | 195.40M |
| Q3 FY2004 | 30 Sept 2004 | 1.92 | 326.20M | 170.30M |
| Q2 FY2004 | 30 Jun 2004 | 2.14 | 333.30M | 156.00M |
| Q1 FY2004 | 31 Mar 2004 | 2.09 | 326.70M | 156.40M |
| Q4 FY2003 | 31 Dec 2003 | 2.15 | 360.20M | 167.20M |
| Q3 FY2003 | 30 Sept 2003 | 2.14 | 368.30M | 172.00M |
| Q2 FY2003 | 30 Jun 2003 | 2.09 | 388.20M | 186.10M |
| Q1 FY2003 | 31 Mar 2003 | 1.85 | 351.10M | 189.60M |
| Q4 FY2002 | 31 Dec 2002 | 1.65 | 326.40M | 197.90M |
| Q3 FY2002 | 30 Sept 2002 | 1.70 | 297.30M | 175.00M |
| Q2 FY2002 | 30 Jun 2002 | 1.67 | 311.70M | 186.10M |
| Q1 FY2002 | 31 Mar 2002 | 1.71 | 287.00M | 167.80M |
| Q4 FY2001 | 31 Dec 2001 | 1.59 | 293.00M | 184.00M |
| Q3 FY2001 | 30 Sept 2001 | 1.75 | 274.90M | 157.40M |
| Q2 FY2001 | 30 Jun 2001 | 1.59 | 316.20M | 199.10M |
| Q1 FY2001 | 31 Mar 2001 | 1.34 | 306.40M | 228.90M |
| Q4 FY2000 | 31 Dec 2000 | 1.29 | 282.00M | 219.00M |
| Q3 FY2000 | 30 Sept 2000 | 1.00 | 277.20M | 277.40M |
| Q2 FY2000 | 30 Jun 2000 | 0.89 | 295.00M | 331.00M |
| Q1 FY2000 | 31 Mar 2000 | 0.96 | 318.00M | 332.00M |
| Q4 FY1999 | 31 Dec 1999 | 2.28 | 356.00M | 156.00M |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about Edwards Lifesciences's current ratio
Source: Financial Modeling Prep